Testing for Alzheimer Disease in Asymptomatic Adults
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This Viewpoint discusses the uncertain prognostic value of testing for Alzheimer disease biomarkers in asymptomatic individuals and warns of the possible insurance, employment, financial, and psychological repercussions of positive results of such tests.
Appeared: Wednesday, October 21. JAMA. Peer-reviewed journal.